Nutraceuticals (Jul 2023)

Super Fruit Amla (<i>Emblica officinalis</i>, Gaertn) in Diabetes Management and Ensuing Complications: A Concise Review

  • Muhammed Majeed,
  • Narayanan K. Narayanan,
  • Lakshmi Mundkur,
  • Priji Prakasan,
  • Kalyanam Nagabhushanam

DOI
https://doi.org/10.3390/nutraceuticals3030026
Journal volume & issue
Vol. 3, no. 3
pp. 329 – 352

Abstract

Read online

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease showing an exponential increase in its prevalence all over the world. High blood glucose level is one of the main clinical signs of the disease. Although several classes of drugs are available for treatment, their prolonged use and adverse effects behoove the use of alternative medicine. Plant-derived natural products have multifaceted beneficial roles in human pathophysiology. Plant metabolites like tannins, organic acids, polyphenols, terpenes, and flavonoids show multiple mechanisms of action against diabetes. The fruits of Emblica officinalis (EOF), also known as Indian gooseberry (amla), contain several phytochemicals, potentially having anti-diabetic activity. Hydrolyzable tannins are the major bioactive components of the amla fruit, the most abundant hydrolyzable tannin being β-glucogallin. The present review summarizes the mechanism of action and clinical evidence for the beneficial effects of EOF on T2DM and its associated complications.

Keywords